ADMS
Adamas Pharmaceuticals
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
63 hedge funds and large institutions have $151M invested in Adamas Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 11 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
23% less capital invested
Capital invested by funds: $196M → $151M (-$45.2M)
Holders
63
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$10.5M | |
| 2 | +$7.66M | |
| 3 | +$4.46M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$3.36M |
| 5 |
Fidelity International
Hamilton,
Bermuda
|
+$2.1M |
Top Sellers
| 1 | -$6.11M | |
| 2 | -$302K | |
| 3 | -$216K | |
| 4 |
Goldman Sachs
New York
|
-$201K |
| 5 |
Morgan Stanley
New York
|
-$186K |